Eton Pharmaceuticals, Inc. (ETON ... by the FDA as a maintenance treatment for patients with Wilson Disease who have been initially treated with a chelating agent. Eton plans to commercialize ...

ANI Pharmaceuticals shares rose Friday morning ... Adjusted earnings before interest, taxes, depreciation and amortization have also been revised higher to a range of $190 million to $200 million.